A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma

NCT00668148 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

113

Enrollment

INDUSTRY

Sponsor class

Conditions

Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET)
Rhabdomyosarcoma
Leiomyosarcoma
Adipocytic Sarcoma
Synovial Sarcoma

Interventions

BIOLOGICAL: IMC-A12 (cixutumumab)
BIOLOGICAL: IMC-A12 (cixutumumab)
BIOLOGICAL: IMC-A12 (cixutumumab)
BIOLOGICAL: IMC-A12 (cixutumumab)
BIOLOGICAL: IMC-A12 (cixutumumab)

Sponsor

Eli Lilly and Company